BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24809162)

  • 1. [Investigation of the recrystallization of trehalose as a good glass-former excipient].
    Katona G; Orsolya JL; Szabóné RP
    Acta Pharm Hung; 2014; 84(1):7-14. PubMed ID: 24809162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of recrystallization of amorphous trehalose through hot-humidity stage X-ray powder diffraction.
    Jójárt-Laczkovich O; Katona G; Aigner Z; Szabó-Révész P
    Eur J Pharm Sci; 2016 Dec; 95():145-151. PubMed ID: 27496047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydration of trehalose dihydrate at low relative humidity and ambient temperature.
    Jones MD; Hooton JC; Dawson ML; Ferrie AR; Price R
    Int J Pharm; 2006 Apr; 313(1-2):87-98. PubMed ID: 16504430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation.
    Fabio K; Curley K; Guarneri J; Adamo B; Laurenzi B; Grant M; Offord R; Kraft K; Leone-Bay A
    AAPS PharmSciTech; 2015 Dec; 16(6):1299-306. PubMed ID: 25776985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical stability of crystalline sugars and their spray-dried forms: dependence upon relative humidity and suitability for use in powder inhalers.
    Naini V; Byron PR; Phillips EM
    Drug Dev Ind Pharm; 1998 Oct; 24(10):895-909. PubMed ID: 9876544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-spray dried carbohydrate microparticles: crystallisation delay/inhibition and improved aerosolization characteristics through the incorporation of hydroxypropyl-β-cyclodextrin with amorphous raffinose or trehalose.
    Amaro MI; Tajber L; Corrigan OI; Healy AM
    Pharm Res; 2015 Jan; 32(1):180-95. PubMed ID: 25074469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Recrystallization of Amorphous Lactose in Nanocomposites Formed by Spray-Drying.
    Hellrup J; Alderborn G; Mahlin D
    J Pharm Sci; 2015 Nov; 104(11):3760-3769. PubMed ID: 26182904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trehalose amorphization and recrystallization.
    Sussich F; Cesàro A
    Carbohydr Res; 2008 Oct; 343(15):2667-74. PubMed ID: 18768170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the physical properties of spray-dried stabilised lysozyme particles.
    Liao YH; Brown MB; Quader A; Martin GP
    J Pharm Pharmacol; 2003 Sep; 55(9):1213-21. PubMed ID: 14604464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable sugar-based protein formulations by supercritical fluid drying.
    Jovanović N; Bouchard A; Sutter M; Van Speybroeck M; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W
    Int J Pharm; 2008 Jan; 346(1-2):102-8. PubMed ID: 17659851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality by design approach in the optimization of the spray-drying process.
    Baldinger A; Clerdent L; Rantanen J; Yang M; Grohganz H
    Pharm Dev Technol; 2012; 17(4):389-97. PubMed ID: 21275777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An anhydrous polymorphic form of trehalose.
    Nagase H; Endo T; Ueda H; Nakagaki M
    Carbohydr Res; 2002 Feb; 337(2):167-73. PubMed ID: 11814449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do co-spray dried excipients offer better lysozyme stabilisation than single excipients?
    Hulse WL; Forbes RT; Bonner MC; Getrost M
    Eur J Pharm Sci; 2008 Mar; 33(3):294-305. PubMed ID: 18262776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules.
    Sou T; Kaminskas LM; Nguyen TH; Carlberg R; McIntosh MP; Morton DA
    Eur J Pharm Biopharm; 2013 Feb; 83(2):234-43. PubMed ID: 23183447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Instability of bacteriophages in spray-dried trehalose powders is caused by crystallization of the matrix.
    Vandenheuvel D; Meeus J; Lavigne R; Van den Mooter G
    Int J Pharm; 2014 Sep; 472(1-2):202-5. PubMed ID: 24950368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of protein on mannitol polymorphic form produced during co-spray drying.
    Hulse WL; Forbes RT; Bonner MC; Getrost M
    Int J Pharm; 2009 Dec; 382(1-2):67-72. PubMed ID: 19682563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of preparation method on physical properties of amorphous trehalose.
    Surana R; Pyne A; Suryanarayanan R
    Pharm Res; 2004 Jul; 21(7):1167-76. PubMed ID: 15290856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of cyclodextrins in antibody microparticles: potentials for antibody protection in spray drying.
    Ramezani V; Vatanara A; Seyedabadi M; Nabi Meibodi M; Fanaei H
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1103-1111. PubMed ID: 28276783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supercritical fluid drying of carbohydrates: selection of suitable excipients and process conditions.
    Bouchard A; Jovanović N; Hofland GW; Jiskoot W; Mendes E; Crommelin DJ; Witkamp GJ
    Eur J Pharm Biopharm; 2008 Mar; 68(3):781-94. PubMed ID: 17702554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.